Enhanc3D Genomics
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Jeffreys Building unit 1 St John's Innov...Phone Number
+44 1223942520Website
www.enhanc3dgenomics.comRevenue
$5.7 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Enhanc3D Genomics
Enhanc3D Genomics is a spinout company from Babraham Institute (Cambridge, UK). It is founded by academic scientists who are leaders in the fields of regulatory genomics and chromosomal architecture. Enhanc3D Genomics is currently supported by StartCodon Accelerator and is based on Cambridge BioMedical Campus.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Enhanc3D Genomics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Enhanc3D Genomics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Enhanc3D Genomics has new funding data
Product Launch: Get notified when Enhanc3D Genomics launches new products
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Enhanc3D Genomics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Enhanc3D Genomics had a recent Job posting/layoffs
Enhanc3D Genomics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Enhanc3D Genomics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Enhanc3D Genomics
Recommended Actions
Reach out to Masked Content who joined Enhanc3D Genomics as Masked Content
Find more new buyers
Compare Similar Companies to Enhanc3D Genomics
Compare insights from companies similar to Enhanc3D Genomics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Enhanc3D Genomics
$5.7M
11-50
Private
$30.3M
2020
N/A
$5.1M
51-200
Private
-
2020
EK
Ednar KabailaInvestment Funds, Capital Markets, Esg Projects Regulatory Analyst
Company Profile Activity
Activity Insights
Enhanc3D Genomics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Enhanc3D Genomics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Enhanc3D Genomics.
Enhanc3D Genomics financials insights
Gather financial insights about Enhanc3D Genomics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series A
$11.3M
2025
Series A
$19M
Enhanc3D Genomics Tech Stack
A closer look at the technologies used by Enhanc3D Genomics
See more technologies
Most Recent Scoops
Funding
Funding
Promotion
Executive Move
Executive Moves, Promotion
New Hire
Executive Move
New Hire
Executive Move
Funding
Enhanc3D Genomics News & Media
Enhanc3D Genomics Appoints Hazel Jones as Chief Executive Officer
CAMBRIDGE, England--(BUSINESS WIRE)--Enhanc3D Genomics, a company developing disruptive technologies to unlock the 3D genome for use in novel target identification and unique patient stratification, today announced the appointment of Hazel Jones as Chief Executive Officer, after a successful six-month tenure as interim CEO and COO. As COO and interim CEO Hazel has overseen the Company's global business operations and held responsibility for executing its strategic vision for commercial and acadEnhanc3D Genomics appoints Dr Daniel Turner as Chief Scientific Officer
CAMBRIDGE, England--(BUSINESS WIRE)--Enhanc3D Genomics, a company developing disruptive technologies to unlock the 3D spatial genome for target and biomarker discovery, today announced the appointment of Dr Daniel Turner as Chief Scientific Officer (CSO). Dan’s deep expertise in genomics technology development and commercialisation will be key to achieving the next phase of Enhanc3D Genomics’ growth. As CSO Dan will be driving Enhanc3D Genomics’ scientific strategy, extending the GenLink3D™ tecEnhanc3D Genomics Expands Leadership Team With the Appointment of Hazel Jones as Chief Operating Officer
CAMBRIDGE, England--(BUSINESS WIRE)--Enhanc3D Genomics, a company developing disruptive technologies to unlock the 3D spatial genome for target and biomarker discovery, today announced the appointment of Hazel Jones as Chief Operating Officer. Following a £10 million Series A financing in October 2022, Hazel’s appointment is the next step in the Company’s drive to broaden the application of its technology and secure strategic collaboration agreements with pharmaceutical partners. Hazel’s new roEnhanc3D Genomics Raises £10M in Series A Financing
Enhanc3D Genomics, a Cambridge, UK-based a functional genomics company, raised £10M in Series A funding. The round was led by BGF, and Parkwalk Advisors, with participation from Bioqube Ventures. The company intends to use the funds to accelerate the development of its proprietary technology platform “GenLink3D“, also expand its team. Led by CEO Debora Lucarelli, Enhanc3D […] The post Enhanc3D Genomics Raises £10M in Series A Financing appeared first on FinSMEs.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Enhanc3D Genomics
Sign Up For FreeTo access detailed company insights
Enhanc3D Genomics is a spinout company from Babraham Institute (Cambridge, UK). It is founded by academic scientists who are leaders in the fields of regulatory genomics and chromosomal architecture. Enhanc3D Genomics is currently supported by StartCodon Accelerator and is based on Cambridge BioMedical Campus.... Read More
